Table 1 Prevalence of the antibody response in 681 individuals infected with Plasmodium vivax
Recombinant protein or synthetic peptides | Prevalence of positive sera (%) | |
|---|---|---|
IgG (n = 681) | IgM (n = 681) | |
VIR-A4 | 91 (13.4) | 123 (18.1) |
VIR-B10 | 103 (15.1) | 116 (17.0) |
VIR-C1 | 123 (18.1) | 113 (16.6) |
VIR-C2 | 157 (23.1) | 146 (21.4) |
VIR25 | 189 (27.8) | 199 (29.2) |
VIR14 | 82 (12.0) | 56 (8.2) |
VIR2 | 45 (6.6) | 43 (6.3) |
PvLP1 | 71 (10.4) | 58 (8.5) |
PvLP2 | 79 (11.6) | 89 (13.1) |
MSP1-19 | 621 (91.2) | ND |